Stuart Therapeutics, Inc.
http://www.stuarttherapeutics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Stuart Therapeutics, Inc.
Deal Watch: Lilly Will Take Over Beam’s Rights To Verve Cardiovascular Assets
Lilly looks To Elektrofi for help on subcutaneous injectable therapies, while NAYA will merge with INVO and acquire two antibodies from Cytovia. Plus deals involving Hummingbird/Endeavor, Basilea/Gravitas/Intron, Lilly/Mablink and Sotio/Synaffix.
Asia Deal Watch: Astellas Begins 2023 Signing Rare Disease Tie-Ups With Selecta, Twist
Evopoint and Kaken also ring in the new year with multiple deals. Biocytogen licenses antibodies against a specified target derived from its RenMice platform technology to Hansoh Pharma.
Big Companies are from Mars, Small Companies from Venus
A review of the Phoenix '97 CEO conference shows there's a long way to go in bridging the communication gap between large and small companies.
Owens & Minor -- The Economics of 'Just Say No'
Back from the brink of financial disaster, distributors are getting healthy with a strategy that draws limits around what they can do for customers and suppliers.
Company Information
- Industry
- Biotechnology
- Other Names / Subsidiaries
-
- Stuart Medical Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice